Unknown

Dataset Information

0

Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease.


ABSTRACT: Sickle cell disease (SCD) is a genetically inherited condition caused by a point mutation in the beta globin gene. This results in the production of the abnormal hemoglobin, sickle hemoglobin (HbS). Hydroxycarbamide, is an antimetabolite/cytotoxic which works by inhibiting ribonucleotide reductase, blocking the synthesis of DNA and arresting cells in the S phase. In sickle cell anemia, it promotes fetal hemoglobin (HbF) synthesis, improves red cell hydration, decreases neutrophil and platelet count, modifies red cell endothelial cell interactions and acts as a nitric oxide donor. Trials have shown the clinical benefit of hydroxycarbamide in a subpopulation of adult patients with SCD, with a 44% reduction in the median annual rate of painful crises, a decrease in the incidence of acute chest syndrome and an estimated 40% reduction in overall mortality over a 9-year observational period. Its use in pediatrics has also been well established; trials have shown it is well tolerated and does not impair growth or development. In addition it decreases the number and duration of hospital attendences. A number of emerging uses of hydroxycarbamide currently are being investigated, such as stroke prevention.

SUBMITTER: Wiles N 

PROVIDER: S-EPMC2754089 | biostudies-literature | 2009

REPOSITORIES: biostudies-literature

altmetric image

Publications

Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease.

Wiles Nm N   Howard J J  

Therapeutics and clinical risk management 20090924


Sickle cell disease (SCD) is a genetically inherited condition caused by a point mutation in the beta globin gene. This results in the production of the abnormal hemoglobin, sickle hemoglobin (HbS). Hydroxycarbamide, is an antimetabolite/cytotoxic which works by inhibiting ribonucleotide reductase, blocking the synthesis of DNA and arresting cells in the S phase. In sickle cell anemia, it promotes fetal hemoglobin (HbF) synthesis, improves red cell hydration, decreases neutrophil and platelet co  ...[more]

Similar Datasets

| S-EPMC9435593 | biostudies-literature
| S-EPMC6478259 | biostudies-literature
| S-EPMC5696022 | biostudies-literature
| S-EPMC4323880 | biostudies-literature
| S-EPMC3373067 | biostudies-literature
2024-10-20 | GSE254951 | GEO
| S-EPMC4668585 | biostudies-literature
| S-EPMC6611562 | biostudies-literature
| S-EPMC7510050 | biostudies-literature
| S-EPMC8034233 | biostudies-literature